Další formáty:
BibTeX
LaTeX
RIS
@inproceedings{488056,
author = {Skrickova, Jana and Babickova, Lenka and Kaplanová, Jana and Kubová, Olga and Pálková, Ivana and Tomísková, Marcela},
address = {Madrid, Spain},
booktitle = {Woorkbook of Iressa Clinical Experience Meeting},
keywords = {non-small-cell lung cancer; gefitinib treatment; antitumour activity;},
language = {cze},
location = {Madrid, Spain},
pages = {81-81},
publisher = {AstraZeneca},
title = {Second-line treatment with gefitinib (Iressa, ZD 1839) in patient with advanced non-small-cell lung cancer.},
year = {2003}
}
TY - JOUR
ID - 488056
AU - Skrickova, Jana - Babickova, Lenka - Kaplanová, Jana - Kubová, Olga - Pálková, Ivana - Tomísková, Marcela
PY - 2003
TI - Second-line treatment with gefitinib (Iressa, ZD 1839) in patient with advanced non-small-cell lung cancer.
PB - AstraZeneca
CY - Madrid, Spain
KW - non-small-cell lung cancer
KW - gefitinib treatment
KW - antitumour activity;
N2 - A case is presented of a 73-year old female non-smoker with advanced, symptomatic NSCLC, initially treated with gemcitabine and carboplatin, but improved only after oral gefitinib 250mg/day, which was well tolerated and demonstrated good antitumour activity.
ER -
SKRICKOVA, Jana, Lenka BABICKOVA, Jana KAPLANOVÁ, Olga KUBOVÁ, Ivana PÁLKOVÁ a Marcela TOMÍSKOVÁ. Second-line treatment with gefitinib (Iressa, ZD 1839) in patient with advanced non-small-cell lung cancer. In \textit{Woorkbook of Iressa Clinical Experience Meeting}. Madrid, Spain: AstraZeneca, 2003, s.~81.
|
